Home

CSL Market Access

Connect with us

Meet with your CSL Behring Associate Director of
Corporate Accounts.

Schedule a meeting

Welcome to CSL Behring Market Access

We are Driven by Our Promise to save and improve lives.

A century’s worth of experience has taught us that innovation, evolution, and collaboration are critical to helping patients live better and longer lives.

In the spirit of collaboration, this online experience is specifically curated to provide essential information to formulary decision-makers about our innovative rare disease therapies. Contact a CSL representative for more information about any of our brands.

Together, we can discover, develop, and deliver high-quality medicines the world needs

Our promise

Learn how CSL’s promise to save lives using the latest innovative medicines continues to deliver advancements to decrease or eliminate the burden of rare diseases.

COAGULATION

Pioneered the first-ever
gene therapy for
hemophilia B

IMMUNOLOGY

A global leader in
immunoglobulin
(Ig) innovation

SPECIALTY

Breaking new ground in
specialty treatments

Our process

For more than 100 years, our manufacturing expertise has supported our efforts to discover, develop, and deliver breakthrough therapies that drive treatment adherence and compliance, lowering overall healthcare resource utilization.

Innovations with value

GENE THEREPIES

Limiting the need for
factor infusions

IMMUNOGLOBULINS

Taking therapies from the
hospital to the home with
subcutaneous Ig

RARE DISEASES

Leading the way on rare and
serious disease

Our pipeline

Our strong R&D pipeline leverages expertise in plasma fractionation, recombinant technology, cell and gene therapy, and vaccines to ease the health and economic burden of unmet needs in the rare disease treatment landscape.